Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, March 25, 2020
[ Wed, Mar 25th 2020
] - WOPRAI
[ Wed, Mar 25th 2020
] - WOPRAI
[ Wed, Mar 25th 2020
] - WOPRAI
[ Wed, Mar 25th 2020
] - WOPRAI
[ Wed, Mar 25th 2020
] - WOPRAI
[ Wed, Mar 25th 2020
] - WOPRAI
[ Wed, Mar 25th 2020
] - WOPRAI
[ Wed, Mar 25th 2020
] - WOPRAI
[ Wed, Mar 25th 2020
] - WOPRAI
[ Wed, Mar 25th 2020
] - WOPRAI
[ Wed, Mar 25th 2020
] - WOPRAI
[ Wed, Mar 25th 2020
] - WOPRAI
[ Wed, Mar 25th 2020
] - WOPRAI
[ Wed, Mar 25th 2020
] - WOPRAI
[ Wed, Mar 25th 2020
] - WOPRAI
[ Wed, Mar 25th 2020
] - WOPRAI
[ Wed, Mar 25th 2020
] - WOPRAI
[ Wed, Mar 25th 2020
] - WOPRAI
[ Wed, Mar 25th 2020
] - WOPRAI
[ Wed, Mar 25th 2020
] - WOPRAI
[ Wed, Mar 25th 2020
] - WOPRAI
[ Wed, Mar 25th 2020
] - WOPRAI
Tue, March 24, 2020
[ Tue, Mar 24th 2020
] - WOPRAI
[ Tue, Mar 24th 2020
] - WOPRAI
Randall Stanicky Maintained (ABBV) at Hold with Decreased Target to $79 on, Mar 24th, 2020
Randall Stanicky of RBC Capital, Maintained "AbbVie Inc." (ABBV) at Hold with Decreased Target from $94 to $79 on, Mar 24th, 2020.
Randall has made no other calls on ABBV in the last 4 months.
There are 4 other peers that have a rating on ABBV. Out of the 4 peers that are also analyzing ABBV, 1 agrees with Randall's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Justin Smith of "Societe Generale" Downgraded from Strong Buy to Hold on, Monday, March 23rd, 2020
These are the ratings of the 3 analyists that currently disagree with Randall
- Steve Scala of "TD Cowen" Maintained at Buy with Increased Target to $105 on, Tuesday, February 18th, 2020
- Vamil Divan of "Mizuho" Maintained at Strong Buy with Increased Target to $104 on, Monday, February 10th, 2020
- Navin Jacob of "UBS" Maintained at Strong Buy with Increased Target to $105 on, Monday, February 10th, 2020
